Puma Bio Rips More Than $100 After-Hours On Trial Results For Breast Cancer
July 22, 2014 at 17:30 PM EDT
Puma Biotechnology (NYSE: PBYI) is trading more than 180 percent higher after-hours as news hit that the company released positive ...